array:23 [ "pii" => "S252991232400041X" "issn" => "25299123" "doi" => "10.1016/j.artere.2024.07.005" "estado" => "S300" "fechaPublicacion" => "2024-07-01" "aid" => "725" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Clin Investig Arterioscler. 2024;36:227-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0214916824000445" "issn" => "02149168" "doi" => "10.1016/j.arteri.2024.06.001" "estado" => "S300" "fechaPublicacion" => "2024-07-01" "aid" => "725" "copyright" => "Sociedad Española de Arteriosclerosis" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Clin Invest Arterioscl. 2024;36:227-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Riesgo trombótico asociado a COVID-19 y diabetes: ¿es PAI-1 el nexo?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "227" "paginaFinal" => "228" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Thrombotic risk associated with COVID-19 and diabetes; Is PAI-1 the link?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José A. Páramo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José A." "apellidos" => "Páramo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S252991232400041X" "doi" => "10.1016/j.artere.2024.07.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S252991232400041X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916824000445?idApp=UINPBA00004N" "url" => "/02149168/0000003600000004/v1_202407071155/S0214916824000445/v1_202407071155/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2529912324000408" "issn" => "25299123" "doi" => "10.1016/j.artere.2024.07.004" "estado" => "S300" "fechaPublicacion" => "2024-07-01" "aid" => "711" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Clin Investig Arterioscler. 2024;36:229-33" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical report</span>" "titulo" => "Family sitosterolemia: Report of two cases in Colombia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "229" "paginaFinal" => "233" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sitosterolemia familiar: reporte de dos casos en Colombia" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1446 "Ancho" => 2091 "Tamanyo" => 115488 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Family tree of the index patient.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alejandro A. Castellanos, María del Carmen Castillo, Laura Montoya, María Elvira Ruiz, Jorge L. Zapateiro, Juan Patricio Nogueira" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Alejandro A." "apellidos" => "Castellanos" ] 1 => array:2 [ "nombre" => "María del Carmen" "apellidos" => "Castillo" ] 2 => array:2 [ "nombre" => "Laura" "apellidos" => "Montoya" ] 3 => array:2 [ "nombre" => "María Elvira" "apellidos" => "Ruiz" ] 4 => array:2 [ "nombre" => "Jorge L." "apellidos" => "Zapateiro" ] 5 => array:2 [ "nombre" => "Juan Patricio" "apellidos" => "Nogueira" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0214916824000196" "doi" => "10.1016/j.arteri.2024.02.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916824000196?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912324000408?idApp=UINPBA00004N" "url" => "/25299123/0000003600000004/v1_202407290723/S2529912324000408/v1_202407290723/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S252991232400038X" "issn" => "25299123" "doi" => "10.1016/j.artere.2024.07.002" "estado" => "S300" "fechaPublicacion" => "2024-07-01" "aid" => "704" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Clin Investig Arterioscler. 2024;36:218-26" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Ultrasound screening for abdominal aortic aneurysm in primary care" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "218" "paginaFinal" => "226" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilidad de la ecografía en el cribado del aneurisma de aorta abdominal en atención primaria" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio López-Téllez, José Manuel Ramírez Torres, Estrella Pérez Vázquez, Miguel Ángel Babiano Fernández, Helena López-Martí, Irene Zapata Martínez, Cristóbal Trillo Fernández, Manuel Frías Vargas, María Dolores Domínguez Pinos, Juan Fernando Peiró Morant, José Antonio González-Fajardo, Pedro Valdivielso Felices" "autores" => array:13 [ 0 => array:2 [ "nombre" => "Antonio" "apellidos" => "López-Téllez" ] 1 => array:2 [ "nombre" => "José Manuel" "apellidos" => "Ramírez Torres" ] 2 => array:2 [ "nombre" => "Estrella" "apellidos" => "Pérez Vázquez" ] 3 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Babiano Fernández" ] 4 => array:2 [ "nombre" => "Helena" "apellidos" => "López-Martí" ] 5 => array:2 [ "nombre" => "Irene" "apellidos" => "Zapata Martínez" ] 6 => array:2 [ "nombre" => "Cristóbal" "apellidos" => "Trillo Fernández" ] 7 => array:2 [ "nombre" => "Manuel" "apellidos" => "Frías Vargas" ] 8 => array:2 [ "nombre" => "María Dolores" "apellidos" => "Domínguez Pinos" ] 9 => array:2 [ "nombre" => "Juan Fernando" "apellidos" => "Peiró Morant" ] 10 => array:2 [ "nombre" => "José Antonio" "apellidos" => "González-Fajardo" ] 11 => array:2 [ "nombre" => "Pedro" "apellidos" => "Valdivielso Felices" ] 12 => array:1 [ "colaborador" => "on behalf of the SEMERGEN Working Group on Vasculopathies" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0214916824000020" "doi" => "10.1016/j.arteri.2023.12.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916824000020?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S252991232400038X?idApp=UINPBA00004N" "url" => "/25299123/0000003600000004/v1_202407290723/S252991232400038X/v1_202407290723/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Thrombotic risk associated with COVID-19 and diabetes; Is PAI-1 the link?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "227" "paginaFinal" => "228" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José A. Páramo" "autores" => array:1 [ 0 => array:4 [ "nombre" => "José A." "apellidos" => "Páramo" "email" => array:1 [ 0 => "japaramo@unav.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Hematología y Hemoterapia, Clínica Universidad de Navarra, Instituto de investigaciones Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Riesgo trombótico asociado a COVID-19 y diabetes: ¿es PAI-1 el nexo?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">It became apparent in the initial periods of the SARS-CoV-2 pandemic (COVID-19) that the disease was associated with severe coagulopathy, which favoured the development of thrombotic complications, leading to high morbidity and mortality in hospitalised patients.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> These complications included venous thromboembolism, myocardial infarction, stroke, and other microvascular complications, mainly at the level of the pulmonary microcirculation, resulting in the development of respiratory distress syndrome and other systemic manifestations, and which could trigger multi-organ failure. These complications were the result of a hypercoagulable state with intravascular fibrin generation and were present in up to 30%–80% of patients admitted to intensive care units and associated with high mortality rates.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> The hypercoagulable state was exacerbated by an impaired fibrinolytic system, the body's defence system responsible for fibrin degradation.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Fibrinolysis is initiated by the conversion of the pro-enzyme plasminogen into the active enzyme plasmin by the action of plasminogen activators (t-PA and u-PA). Plasmin is responsible for the proteolytic degradation of fibrin, resulting in the generation of degradation products, D-dimer being the most relevant in patients with COVID-19, as extraordinarily high levels are observed after infection.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> This system is tightly regulated by the action of plasminogen activator inhibitors, such as PAI-1, and plasmin, to prevent excessive fibrinolysis that would promote bleeding, while an excess of PAI-1 would contribute to a hypofibrinolytic state that promotes thrombosis.</p><p id="par0015" class="elsevierStylePara elsevierViewall">SARS-CoV-2 has been reported to induce PAI-1 expression by endothelial cells and may be the link between cardiovascular risk factors (smoking, diabetes, etc.) and the clinical manifestations of COVID-1 infection.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Previous studies have shown PAI-1-mediated fibrinolytic resistance and a significant increase in PAI-1 inhibitor in patients with COVID-19, up to 4 times higher than that observed in controls, which would lead to decreased fibrinolysis.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5–7</span></a> Some studies have shown that up to 80% of patients with COVID-19 and thrombosis meet the criteria for fibrinolytic shutdown, and its association with the presence of thrombosis in the microcirculation in the lung and other organs (kidney, brain, etc., etc.).<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8–10</span></a> Finally, the persistence of a hypofibrinolytic state is associated with an unfavourable prognosis, as it is associated with the severity of the infection.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11,12</span></a> Consequently, the haemostatic coagulation/fibrinolysis balance is altered in these patients, with activation of coagulation and decreased fibrinolysis, resulting in a hypercoagulable state that promotes thrombosis.</p><p id="par0020" class="elsevierStylePara elsevierViewall">It is known that type 2 diabetes mellitus (DM) and associated hyperglycaemia carries a high risk of thromboembolic complications.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> It is also known that patients with DM have platelet hyperactivity and haemostatic disturbances and other comorbidities (obesity, dyslipidaemia, fatty liver, etc.), which contribute to a hypercoagulable state. However, it is not known whether the presence of hyperglycaemia and/or type 2 DM would aggravate this state should these patients suffer COVID-19 infection. Previous studies have described a close relationship between PAI-1 and diabetes, which could favour the development of thrombotic complications and may be a link in patients with COVID-19.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In this issue of <span class="elsevierStyleItalic">Clínica e Investigación en Arteriosclerosis,</span> Basurto et al. analyse the association between PAI-1 and DM/hyperglycaemia in a large population of 181 patients hospitalised for COVID-19, of whom 38% had a previous history of DM and 51% had pre-existing hyperglycaemia and/or DM.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> They observed a significant increase in PAI-1 in this group of patients in relation to non-hyperglycaemic hospitalised patients. They also demonstrated a correlation between inhibitor and glucose levels and an association of PAI-1, hyperglycaemia, and/or DM with COVID-19 severity. This suggests that hyperglycaemia may contribute to the hypercoagulable state. This is the largest series to examine this association, as a previous study involving 30 patients with COVID-19 and DM had also observed a significant increase in PAI-1.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> The most relevant finding of the study by Basurto et al. stems not only from the association between glucose levels and PAI-1, but also from the potential prognostic significance of this fibrinolytic biomarker in patients with DM, due to its relationship with the severity of COVID-19 infection. The authors acknowledge some inherent limitations of the study, as the determination of only one of the fibrinolytic components, PAI-1, does not provide information on the overall fibrinolytic activity.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In summary, when patients with hyperglycaemia and/or DM are infected by COVID-19, their thrombotic risk is significantly increased, and PAI-1 plays a key role in the hypercoagulable state associated with coagulopathy. This is of interest because of the possibility of inhibiting PAI-1 as a new antithrombotic strategy in these patients.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0035" class="elsevierStylePara elsevierViewall">The author declares that this study has not received any funding.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflict of interests</span><p id="par0040" class="elsevierStylePara elsevierViewall">The author has no conflict of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflict of interests" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:17 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.A. Páramo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reumae.2020.06.007" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin (Engl Ed)" "fecha" => "2022" "volumen" => "18" "paginaInicial" => "1" "paginaFinal" => "4" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35090606" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Nougier" 1 => "R. Benoit" 2 => "M. Simon" 3 => "H. Desmurs-Clavel" 4 => "G. Marcotte" 5 => "L. Argaud" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jth.15016" "Revista" => array:6 [ "tituloSerie" => "J Thromb Haemost" "fecha" => "2020" "volumen" => "18" "paginaInicial" => "2215" "paginaFinal" => "2219" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32668058" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Kruse" 1 => "A. Magomedov" 2 => "A. Kurreck" 3 => "F.H. Münch" 4 => "R. Koerner" 5 => "J. Kamhieh-Milz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13054-020-03401-8" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2020" "volumen" => "24" "paginaInicial" => "676" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33287877" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19-associated coagulopathy: less fibrinolysis may be more harmful" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Görlinger" 1 => "J.H. Levy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ALN.0000000000003688" "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2021" "volumen" => "134" "paginaInicial" => "366" "paginaFinal" => "369" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33417671" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The central role of PAI-1 in COVID-19: thrombosis and beyond" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S.S. Khan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1165/rcmb.2021-0208ED" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Cell Mol Biol" "fecha" => "2021" "volumen" => "65" "paginaInicial" => "238" "paginaFinal" => "240" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34086538" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Suppression of fibrinolysis and hypercoagulability, severity of hypoxemia, and mortality in COVID-19 patients: a retrospective cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.M. Corey" 1 => "L.B. Olson" 2 => "I.A. Naqvi" 3 => "S.A. Morrison" 4 => "C. Davis" 5 => "S.M. Nimjee" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ALN.0000000000004239" "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2022" "volumen" => "137" "paginaInicial" => "67" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35412597" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.H. Toomer" 1 => "G.F. Gerber" 2 => "Y. Zhang" 3 => "L. Daou" 4 => "M. Tushek" 5 => "J.E. Hooper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jha2.654" "Revista" => array:6 [ "tituloSerie" => "EJHaem" "fecha" => "2023" "volumen" => "4" "paginaInicial" => "324" "paginaFinal" => "338" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/37206290" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Wright" 1 => "T.O. Vogler" 2 => "E.E. Moore" 3 => "H.B. Moore" 4 => "M.V. Wohlauer" 5 => "S. Urban" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jamcollsurg.2020.05.007" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Surg" "fecha" => "2020" "volumen" => "231" "paginaInicial" => "193" "paginaFinal" => "203" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32422349" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.P. Meizoso" 1 => "H.B. Moore" 2 => "E.E. Moore" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Coll Surg" "fecha" => "2021" "volumen" => "232" "paginaInicial" => "995" "paginaFinal" => "1003" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrinolysis shutdown and thrombosis in a COVID-19 ICU" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Creel-Bulos" 1 => "S.C. Auld" 2 => "M. Caridi-Scheible" 3 => "N.A. Barker" 4 => "S. Friend" 5 => "M. Gaddh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/SHK.0000000000001635" "Revista" => array:6 [ "tituloSerie" => "Shock" "fecha" => "2021" "volumen" => "55" "paginaInicial" => "316" "paginaFinal" => "320" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32769822" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circulating levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are independent predictors of coronavirus disease 2019 severity: a prospective, observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B.M. Henry" 1 => "I. Cheruiyot" 2 => "J.L. Benoit" 3 => "G. Lippi" 4 => "Z. Prohászka" 5 => "E.J. Favaloro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Semin Thromb Hemos" "fecha" => "2021" "volumen" => "47" "paginaInicial" => "451" "paginaFinal" => "455" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Okazaki" 1 => "B.G. Barion" 2 => "T.R.F. da Rocha" 3 => "G. Di Giacomo" 4 => "Y.L. Ho" 5 => "C. Rothschild" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11239-024-02961-8" "Revista" => array:6 [ "tituloSerie" => "J Thromb Thrombolysis" "fecha" => "2024" "volumen" => "57" "paginaInicial" => "721" "paginaFinal" => "729" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/38523179" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SEA 2024 standards for global control of vascular risk" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Mostaza" 1 => "X. Pintó" 2 => "P. Armario" 3 => "L. Masana" 4 => "J.T. Real" 5 => "P. Valdivielso" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Invest Arterioscler" "fecha" => "2024" "volumen" => "36" "paginaInicial" => "133" "paginaFinal" => "194" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PAI-1 in diabetes: pathophysiology and role as a therapeutic target" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Altalhi" 1 => "N. Pechlivani" 2 => "R.A. Ajjan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms22063170" "Revista" => array:5 [ "tituloSerie" => "Int J Mol Sci" "fecha" => "2021" "volumen" => "22" "paginaInicial" => "3170" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33804680" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thrombotic risk assessed by PAI-1 in patients with COVID -19: The influence of hyperglycemia and diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Basurto" 1 => "L. Manuel-Apolinar" 2 => "A. Robledo" 3 => "S. O’Leary" 4 => "C. Martinez-Murillo" 5 => "L.I. Medina-Ortiz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arteri.2023.12.004" "Revista" => array:2 [ "tituloSerie" => "Clin Invest Arterioscler" "fecha" => "2024" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Platelet protein-related abnormalities in response to acute hyperglycemia in type2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.S.M. Moin" 1 => "A. Al-Qaissi" 2 => "T. Sathyapaln" 3 => "S.L. Atkin" 4 => "A.I. Butler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fendo.2021.651009" "Revista" => array:3 [ "tituloSerie" => "Front Endocrinol" "fecha" => "2021" "volumen" => "12" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapeutic potential of targeting plasminogen activator inhibitor-1 in COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T.F. Kellici" 1 => "E.S. Pilka" 2 => "M.J. Bodkin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.tips.2021.03.006" "Revista" => array:6 [ "tituloSerie" => "Trends Pharmacol Sci" "fecha" => "2021" "volumen" => "42" "paginaInicial" => "431" "paginaFinal" => "433" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33867130" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25299123/0000003600000004/v1_202407290723/S252991232400041X/v1_202407290723/en/main.assets" "Apartado" => array:4 [ "identificador" => "63723" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25299123/0000003600000004/v1_202407290723/S252991232400041X/v1_202407290723/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S252991232400041X?idApp=UINPBA00004N" ]
Journal Information
Vol. 36. Issue 4.
Pages 227-228 (July - August 2024)
Share
Download PDF
More article options
Vol. 36. Issue 4.
Pages 227-228 (July - August 2024)
Editorial
Thrombotic risk associated with COVID-19 and diabetes; Is PAI-1 the link?
Riesgo trombótico asociado a COVID-19 y diabetes: ¿es PAI-1 el nexo?
Visits
30
José A. Páramo
Corresponding author
Servicio de Hematología y Hemoterapia, Clínica Universidad de Navarra, Instituto de investigaciones Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain
This item has received
Article information
These are the options to access the full texts of the publication Clínica e Investigación en Arteriosclerosis (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail